The National Inherited Bleeding Disorder Genotyping Laboratory (NIBDGL) was founded in 2000 to provide molecular diagnostic testing for hemophilia A, hemophilia B, von Willebrand disease, and rare bleeding disorders.
The laboratory is supported by the Association of Hemophilia Clinic Directors of Canada, and by the Queen’s University Department of Pathology and Molecular Medicine.
Tests may only be ordered by care givers from Canadian hemophilia comprehensive care centers and from clinical genetics clinics across Canada.
The lab is licenced by the Ministry of Health and Long-term Care (MOHLTC) to provide molecular diagnostics for hemophilia A, hemophilia B and von Willebrand disease.
The lab is accredited by Accreditation Canada Diagnostics (formerly Institute for Quality Management in Healthcare (IQMH)) to ISO 15189.
WHO WE ARE
Laboratory Director: Dr. David Lillicrap, MD FRCPC
Laboratory Co-Director: Dr. Harriet Feilotter, PhD FCCMG
Medical Laboratory Technologist: Gina Jones, MLT
Medical Genetics Technician: Samira Kheitan, MSc
Medical Genetics Technician: Aomei Mo
Senior Clinical Scientist: Dr. Mackenzie Bowman, PhD
DATA PRIVACY AND ACCESS TO INFORMATION
The NIBDGL is committed to ensuring the privacy and confidentiality of all collected information in accordance with all legal requirements. For any inquiries into the NIBDGL’s information practices, please contact us at NIBDGL@queensu.ca. To obtain access to your report, please contact your referring clinician.
The NIBDGL (Queen’s University) is situated on the territory of the Haudenosaunee and Anishinaabek.
Ne Queen’s University e’tho nón:we nikanónhsote tsi nón:we ne Haudenosaunee táhnon Anishinaabek tehatihsnonhsáhere ne onhwéntsya.
Gimaakwe Gchi-gkinoomaagegamig atemagad Naadowe miinwaa Anishinaabe aking.